Clay B. Siegall
President and CEO at Immunome Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Immunome Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Shattuck Labs Inc. May 28, 202693.0%
-
Immunome Inc. June 12, 202499.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 2026 | Immunome Inc. | Grant or award | +180,000 | — | — |
| Jun 9, 2026 | Shattuck Labs Inc. | Open-market purchase | +62,500 | $4.00 | $250,000 |
| May 22, 2026 | Shattuck Labs Inc. | Grant or award | +128,054 | $1.08 | $138,298 |
| Mar 27, 2026 | Immunome Inc. | Open-market purchase | +25,450 | $19.67 | $500,602 |
| Dec 30, 2025 | Immunome Inc. | Open-market purchase | +4,729 | $21.15 | $100,018 |
| Dec 19, 2025 | Immunome Inc. | Open-market purchase | +7,278 | $20.48 | $149,053 |
| Dec 19, 2025 | Immunome Inc. | Gift | −200,000 | — | — |
| Dec 18, 2025 | Immunome Inc. | Open-market purchase | +46,511 | $21.50 | $999,987 |
| Aug 25, 2025 | Shattuck Labs Inc. | Grant or award | +128,054 | $0.87 | $111,407 |
| Mar 26, 2025 | Immunome Inc. | Open-market purchase | +137,100 | $7.29 | $999,459 |
| Jan 31, 2025 | Immunome Inc. | Open-market purchase | +150,000 | $7.75 | $1,162,500 |
| Nov 22, 2024 | Immunome Inc. | Open-market purchase | +33,943 | $9.78 | $331,963 |
| Nov 21, 2024 | Immunome Inc. | Open-market purchase | +66,057 | $9.54 | $630,184 |
| May 21, 2024 | Immunome Inc. | Open-market purchase | +20,434 | $13.78 | $281,581 |
| May 20, 2024 | Immunome Inc. | Open-market purchase | +79,566 | $13.91 | $1,106,763 |
Questions about Clay B. Siegall
What boards is Clay B. Siegall on?
Clay B. Siegall sits on the boards of Immunome Inc. and Shattuck Labs Inc.
What company is Clay B. Siegall the CEO of?
Clay B. Siegall has been President and CEO of Immunome Inc. since October 2023.
How long has Clay B. Siegall served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.